Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Congress Asset Management Co.

Congress Asset Management Co. increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 312,708 shares of the medical equipment provider’s stock after acquiring an additional 5,078 shares during the period. Intuitive Surgical makes up approximately 1.2% of Congress Asset Management Co.’s portfolio, making the stock its 15th biggest holding. Congress Asset Management Co. owned 0.09% of Intuitive Surgical worth $154,875,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ISRG. Sycomore Asset Management boosted its position in Intuitive Surgical by 27.4% during the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after purchasing an additional 4,079 shares in the last quarter. Castleark Management LLC boosted its position in Intuitive Surgical by 3.4% during the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider’s stock worth $47,221,000 after purchasing an additional 2,990 shares in the last quarter. Truist Financial Corp boosted its position in Intuitive Surgical by 3.0% during the fourth quarter. Truist Financial Corp now owns 248,092 shares of the medical equipment provider’s stock worth $129,494,000 after purchasing an additional 7,298 shares in the last quarter. Global X Japan Co. Ltd. boosted its position in Intuitive Surgical by 9.8% during the fourth quarter. Global X Japan Co. Ltd. now owns 46,289 shares of the medical equipment provider’s stock worth $24,161,000 after purchasing an additional 4,140 shares in the last quarter. Finally, Northeast Investment Management boosted its position in Intuitive Surgical by 3.1% during the fourth quarter. Northeast Investment Management now owns 89,170 shares of the medical equipment provider’s stock worth $46,543,000 after purchasing an additional 2,685 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.2%

NASDAQ ISRG opened at $557.08 on Friday. The business’s 50-day moving average price is $521.99 and its 200 day moving average price is $539.26. Intuitive Surgical, Inc. has a twelve month low of $413.52 and a twelve month high of $616.00. The company has a market capitalization of $199.67 billion, a PE ratio of 86.91, a price-to-earnings-growth ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period in the prior year, the business posted $1.50 earnings per share. Equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 215 shares of the firm’s stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $549.06, for a total value of $118,047.90. Following the transaction, the senior vice president now directly owns 1,768 shares in the company, valued at $970,738.08. This trade represents a 10.84% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the firm’s stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the transaction, the director now owns 6,371 shares in the company, valued at approximately $3,312,920. This trade represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 25,443 shares of company stock worth $12,692,195 in the last three months. 0.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of analysts have commented on the company. Barclays decreased their target price on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a research report on Thursday, April 24th. Evercore ISI decreased their target price on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a research report on Wednesday, April 23rd. Citigroup reiterated a “buy” rating and set a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Piper Sandler decreased their price objective on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 23rd. Finally, Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Thursday. Four investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $596.05.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.